Who Exports Tacrolimus from India — 299 Suppliers Behind a $201.2M Market
India's tacrolimus export market is supplied by 299 active exporters who collectively shipped $201.2M across 4,611 shipments. SANDOZ PRIVATE LIMITED leads with a 38.2% market share, followed by ALKEM LABORATORIES LIMITED and THE MADRAS PHARMACEUTICAL. The top 5 suppliers together control 80.2% of total export value, reflecting a concentrated market structure.

Top Tacrolimus Exporters from India — Ranked by Export Value
SANDOZ PRIVATE LIMITED is the leading tacrolimus exporter from India, holding a 38.2% share of the $201.2M market across 4,611 shipments from 299 exporters. The top 5 suppliers — SANDOZ PRIVATE LIMITED, ALKEM LABORATORIES LIMITED, THE MADRAS PHARMACEUTICAL, INTAS PHARMACEUTICALS LIMITED, PANACEA BIOTEC PHARMA LIMITED — collectively control 80.2% of total export value, indicating a highly concentrated market. Individual shares are: SANDOZ PRIVATE LIMITED (38.2%), ALKEM LABORATORIES LIMITED (16.1%), THE MADRAS PHARMACEUTICAL (11.2%), INTAS PHARMACEUTICALS LIMITED (11.2%), PANACEA BIOTEC PHARMA LIMITED (3.5%).
Top Tacrolimus Exporters from India
Ranked by export value · 299 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SANDOZ PRIVATE LIMITED TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293TACROLIMUS CAPSULES USP 1MG [6240 PACK X 100'S]( | $76.9M | 14 | 38.2% |
| 2 | ALKEM LABORATORIES LIMITED TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293TACROLIMUS CAPSULES USP 1MG [6240 PACK X 100'S]( | $32.5M | 3 | 16.1% |
| 3 | THE MADRAS PHARMACEUTICAL ROCIMUS 0.1% W/W (TACROLIMUS OINTMENT 0.ROCIMUS 0.03% W/W (TACROLIMUS OINTMENT 0ROCIMUS 0.01% W/W TACROLIMUS OINTMENT 0 | $22.6M | 4 | 11.2% |
| 4 | INTAS PHARMACEUTICALS LIMITED TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293TACROLIMUS CAPSULES USP 1MG [6240 PACK X 100'S]( | $22.5M | 13 | 11.2% |
| 5 | PANACEA BIOTEC PHARMA LIMITED TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293TACROLIMUS CAPSULES USP 1MG [6240 PACK X 100'S]( | $6.9M | 19 | 3.5% |
| 6 | DR.REDDY'S LABORATORIES LTD TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293TACROLIMUS CAPSULES USP 1MG [6240 PACK X 100'S]( | $5.7M | 4 | 2.8% |
| 7 | BIOCON PHARMA LIMITED TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293TACROLIMUS CAPSULES USP 1MG [6240 PACK X 100'S]( | $4.3M | 2 | 2.1% |
| 8 | STRIDES PHARMA SCIENCE LIMITED TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293TACROLIMUS CAPSULES USP 1MG [6240 PACK X 100'S]( | $4.0M | 6 | 2.0% |
| 9 | DR REDDYS LABORATORIES LIMITED ROCIMUS 0.1% W/W (TACROLIMUS OINTMENT 0.TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293 | $3.3M | 2 | 1.6% |
| 10 | CARITAS HEALTHCARE PRIVATE LIMITED TACROLIMUS CAPSULES 1MG 5 X10#S MEXICOTACROLIMUS CAPSULES 1MGTACROLIMUS CAPSULES 1MG 5 X10#S | $3.0M | 2 | 1.5% |
| 11 | DR REDDY S LABORATORIES LIMITED ROCIMUS 0.1% W/W (TACROLIMUS OINTMENT 0.TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293 | $2.5M | 2 | 1.2% |
| 12 | GLENMARK PHARMACEUTICALS LIMITED ROCIMUS 0.1% W/W (TACROLIMUS OINTMENT 0.TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293 | $2.1M | 13 | 1.0% |
| 13 | ENCUBE ETHICALS PRIVATE LIMITED TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293TACROLIMUS CAPSULES USP 1MG [6240 PACK X 100'S]( | $2.0M | 1 | 1.0% |
| 14 | GLENMARK PHARMACEUTICALS LTD ROCIMUS 0.1% W/W (TACROLIMUS OINTMENT 0.TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293 | $1.5M | 1 | 0.8% |
| 15 | DR.REDDY'S LABORATORIES LIMITED TACROLIMUS CAPSULES USP 1MG [18462 PACK X 100'S] (TACROLIMUS 1MG 100HGC BO US MATERIAL NO.- 44010293TACROLIMUS CAPSULES USP 1MG [6240 PACK X 100'S]( | $1.1M | 2 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Tacrolimus exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Warning Letter, July 2025 | Unknown | Unknown | Not verified | FDA issued a warning letter citing CGMP violations at the Pithampur, Indore faci |
| Dr. Reddy's Laboratories Ltd. | Warning Letter, November | Unknown | Unknown | Not verified | FDA issued a warning letter for CGMP violations at three facilities. |
| Intas Pharmaceuticals Limited | Unknown | Unknown | Yes | Not verified | Intas's Biologics Unit received EU GMP certification in April 2007. |
| Global Pharma Healthcare Private Limited | Warning Letter, October 2 | Unknown | Unknown | Not verified | FDA issued a warning letter citing CGMP violations at the Thiruporur facility. |
TransData Nexus reviewed the regulatory standing of 4 leading Tacrolimus exporters from India. 0 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 1 are EU GMP compliant. 3 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Tacrolimus sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous manufacturing facilities that produce a wide range of APIs, including Tacrolimus. Companies in this region benefit from well-established infrastructure, a skilled workforce, and proximity to research institutions, facilitating efficient production and innovation in bulk drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to several leading pharmaceutical companies that specialize in the development and production of finished dosage forms. The presence of a robust supply chain, coupled with regulatory compliance, positions this cluster as a key player in the formulation of drugs like Tacrolimus.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for Indian pharmaceuticals. With access to major ports and international airports, this region facilitates the efficient export of pharmaceutical products to global markets. The concentration of export-oriented units in this area underscores its significance in the global supply chain for drugs such as Tacrolimus.
4Baddi-Nalagarh — Tax Incentive Zone
Located in Himachal Pradesh, the Baddi-Nalagarh region has emerged as a prominent pharmaceutical manufacturing zone, largely due to favorable tax incentives and supportive government policies. This area attracts numerous pharmaceutical companies, contributing significantly to the production capacity for various drugs, including immunosuppressants like Tacrolimus.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and regulatory compliance of suppliers, particularly those in the Hyderabad and Ahmedabad-Vadodara regions, to ensure consistent quality and supply of Tacrolimus.
- Leverage Export Infrastructure: Utilize the logistical advantages offered by the Mumbai-Thane-Raigad cluster to streamline the export process and reduce lead times.
- Monitor Regulatory Changes: Stay informed about policy developments in tax incentive zones like Baddi-Nalagarh to capitalize on cost-saving opportunities and ensure compliance with evolving regulations.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Tacrolimus exporters from India
Panacea Biotec Pharma Limited — Panacea Biotec Pharma sells assets to Mankind Pharma
Panacea Biotec Pharma Limited entered into an asset purchase agreement with Mankind Pharma Limited on February 28, 2022, transferring certain assets to Mankind Pharma. - IMPACT: This divestment may influence Panacea Biotec's Tacrolimus export capabilities.
Impact: This divestment may influence Panacea Biotec's Tacrolimus export capabilities.
Alembic Pharmaceuticals Limited — Alembic Pharma acquires Aleor Dermaceuticals
Alembic Pharmaceuticals acquired a 100% stake in Aleor Dermaceuticals in March 2022, enhancing its dermatology portfolio. - IMPACT: While not directly related to Tacrolimus, this acquisition could bolster Alembic's overall export capabilities.
Impact: While not directly related to Tacrolimus, this acquisition could bolster Alembic's overall export capabilities.
Sun Pharmaceutical Industries Limited — Sun Pharma merges with Taro Pharmaceuticals
Sun Pharma completed a definitive merger with Taro Pharmaceuticals in January 2024, acquiring the remaining stake for $347.73 million. - IMPACT: This merger may enhance Sun Pharma's position in the Tacrolimus market.
Impact: This merger may enhance Sun Pharma's position in the Tacrolimus market.
Common Questions — Tacrolimus Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which tacrolimus supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SANDOZ PRIVATE LIMITED leads with 737 recorded shipments worth $76.9M. ALKEM LABORATORIES LIMITED (168 shipments) and THE MADRAS PHARMACEUTICAL (19 shipments) are also established high-volume exporters.
Q How many tacrolimus manufacturers are there in India?
India has 299 active tacrolimus exporters with a combined export market of $201.2M across 4,611 shipments to 127 countries. The top 5 suppliers hold 80.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for tacrolimus from India?
Average FOB unit price: $68.32 per unit, ranging from $0.01 to $53721.02. Average shipment value: $43.6K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 299 verified Indian exporters of Tacrolimus ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,611 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 127 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,611 Verified Shipments
299 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists